Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

12.45
-0.1000-0.80%
Post-market: 12.42-0.0300-0.24%19:04 EDT
Volume:250.00K
Turnover:3.12M
Market Cap:213.53M
PE:-1.00
High:12.90
Open:12.89
Low:12.25
Close:12.55
52wk High:37.56
52wk Low:9.40
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.66
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.96
PE(LYR):-0.85

Loading ...

Apr 22, 2020

Major Issues Report

Current report, items 3.01, 7.01, and 9.01
Apr 20, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Apr 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Apr 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Apr 08, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Mar 24, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Mar 24, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 03, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Feb 28, 2020

Major Issues Report

8-K - Current report
Feb 26, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 07, 2020

Major Issues Report

Current report, items 1.01, 5.03, 8.01, and 9.01